Majority Of Psychedelic Drug Stocks Index Constituents Continue To Advance

The number of companies doing research into the development of psychedelic compounds to treat mental health problems such as depression and addiction now numbers 38 of which 15 are included in the Pure-Play Psychedelic Drug Stocks Index.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.